Pluto Health’s Commitment to Early Detection - Hepatitis C Screening and Lymphoma Prevention

September is Lymphoma Awareness Month, a time dedicated to increasing public awareness about lymphoma - a type of bloodborne cancer. While many possible factors can contribute to a person developing lymphoma, one relatively unrecognized risk factor is Hepatitis C virus (HCV) infection. Studies have shown that people with HCV are more likely to develop non-Hodgkin lymphoma, a common subtype of lymphoma. This connection makes it really important to screen for Hepatitis C, especially in those who might be at higher risk.

Understand how crucial it is to catch Hepatitis C early to reduce this risk factor for lymphoma. It is estimated that anywhere from 2.5-4 million people in the United States have chronic HCV. Because Hepatitis C often doesn’t show signs in the early stages, it can go unnoticed until it causes serious damage, like inflammation and liver disease, which can lead to lymphoma. Pluto Health offers an easy way to initially test for Hepatitis C at home, allowing people to find out if they have the virus before it causes major problems. Catching the virus early means that it can be treated sooner, which lowers the risk of it leading to lymphoma and helps people stay healthier overall.

In addition to making testing easy, Pluto Health makes sure that anyone who tests positive for Hepatitis C gets the follow up care they need right away. We connect patients to doctors who specialize in treating the virus, so they can start treatment as soon as possible. As we observe Lymphoma Awareness Month, it’s important to highlight how Pluto Health’s commitment to early detection through at-home testing and coordinated care is making a impact in the fight against both Hepatitis C and lymphoma, ultimately enhancing access to and quality of care for at-risk populations.